HR1524: HR1524 General Assembly; reschedule marijuana from a Schedule I substance to a Schedule III substance in accordance with presidential Executive Order 14370; urge

Marijuana is currently classified under federal law as a Schedule I controlled substance, meaning it is officially treated as having no accepted medical use and a high potential for abuse. This House resolution points to federal reviews by the Food and Drug Administration and the Department of Health and Human Services, which found evidence that marijuana has accepted medical uses for pain, nausea, and appetite loss, and recommended moving it to the less restrictive Schedule III category. It also references a December 2025 presidential executive order directing the U.S. Attorney General to speed up that federal rescheduling process. The resolution itself does not change Georgia law or federal law. It formally urges the Georgia General Assembly to reschedule marijuana from Schedule I to Schedule III and to take steps to increase research into medical marijuana and cannabidiol. It also directs the Speaker of the House to distribute copies of the resolution to the General Assembly.

• Expresses the House of Representatives' position urging the Georgia General Assembly to reschedule marijuana from Schedule I to Schedule III.
• Urges the General Assembly to take steps to increase medical marijuana and cannabidiol research to inform patients and doctors.
• Directs the Speaker of the House to make copies of the resolution available for distribution to the Georgia General Assembly.
• Does not itself amend any Georgia statute or change the legal classification of marijuana under state or federal law.

The resolution primarily concerns the Georgia General Assembly itself, since it is addressed to that body. It also touches patients using or seeking medical marijuana, healthcare practitioners who recommend it, and researchers studying marijuana and cannabidiol, since it calls for expanded research and rescheduling.

Because this is a resolution rather than a bill, it carries no legal force on its own; marijuana's classification in Georgia does not change unless separate legislation follows. Its practical effect is to put the House's position on record and potentially build momentum for future bills changing marijuana's legal status or funding research.

• Recites findings from a 2023 FDA review supporting marijuana's medical use for pain, nausea, and appetite loss.
• Notes that HHS recommended in 2023 that the DEA reclassify marijuana as Schedule III, and that a Department of Justice proposed rule from May 2024 is still pending.
• References a December 18, 2025 presidential executive order directing the U.S. Attorney General to expedite the federal rescheduling process under 21 U.S.C. Section 811.
• The resolving clause urges the Georgia General Assembly to reschedule marijuana to Schedule III and expand medical marijuana and cannabidiol research.
• Directs the Speaker of the House to distribute copies of the resolution to the General Assembly.

1. 2026-03-06House Second Readers (House)
2. 2026-03-04House First Readers (House)
3. 2026-03-03House Hopper (House)

• Eric Bell (D, HD-075)Primary sponsor
• Derrick Jackson (D, HD-068)
• El-Mahdi Holly (D, HD-116)
• Spencer Frye (D, HD-122)
• Samuel Park (D, HD-107)

• medical marijuana
• drug scheduling
• cannabis policy
• medical research